Clinical Performance of NIPT in Multiple Gestation Pregnancies

Clinical Performance of NIPT (Noninvasive Prenatal Testing) in Multiple Gestation Pregnancies (SCMM-T21-110)

This study plans to evaluate the clinical performance of the MaterniT21 PLUS and/or GENOME Laboratory Developed Test, in the detection of fetal trisomy 21 in circulating cell-free DNA extracted from maternal blood samples obtained from women pregnant with a twin gestation.

Inclusion Criteria:

• subject pregnant with a multiple gestation and received NIPT from Sequenom Laboratories;
• subject was 18 or older at the time of NIPT

Exclusion Criteria:

• none